Baird Financial Group’s Enzo Biochem, Inc. ENZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-15,000
| Closed | -$36.5K | – | 1771 |
|
|
2023
Q1 | $36.5K | Hold |
15,000
| – | – | ﹤0.01% | 1672 |
|
|
2022
Q4 | $21K | Hold |
15,000
| – | – | ﹤0.01% | 1674 |
|
|
2022
Q3 | $33K | Hold |
15,000
| – | – | ﹤0.01% | 1687 |
|
|
2022
Q2 | $31K | Hold |
15,000
| – | – | ﹤0.01% | 1759 |
|
|
2022
Q1 | $44K | Hold |
15,000
| – | – | ﹤0.01% | 1787 |
|
|
2021
Q4 | $48K | Hold |
15,000
| – | – | ﹤0.01% | 1863 |
|
|
2021
Q3 | $53K | Hold |
15,000
| – | – | ﹤0.01% | 1845 |
|
|
2021
Q2 | $48K | Hold |
15,000
| – | – | ﹤0.01% | 1731 |
|
|
2021
Q1 | $52K | Hold |
15,000
| – | – | ﹤0.01% | 1676 |
|
|
2020
Q4 | $38K | Hold |
15,000
| – | – | ﹤0.01% | 1559 |
|
|
2020
Q3 | $32K | Hold |
15,000
| – | – | ﹤0.01% | 1478 |
|
|
2020
Q2 | $34K | Hold |
15,000
| – | – | ﹤0.01% | 1498 |
|
|
2020
Q1 | $38K | Buy |
+15,000
| New | +$38K | ﹤0.01% | 1403 |
|